Levitee Labs (CSE:LVT) Inc. told investors that its common shares have been accepted for listing on the Frankfurt Stock Exchange (FSE) under the trading symbol 7H7.
The company said it expects the listing may increase trading liquidity in its stock and facilitate investment opportunities from investors in Germany, Switzerland, Luxembourg, and the rest of Europe.
Following the listing on the FSE, Levitee said its shares are now cross-listed on three exchanges, which also include the Canadian Securities Exchange and OTC Markets.
READ: Levitee Labs completes acquisition of superfoods provider Earth Circle Organics Chain
"Since our initial listing in Canada, we have been fortunate to receive inquiries from investors internationally," founder and CEO Pouya Farmand said in a statement. “It has been an important priority for the company to make our shares available to investors outside of Canada, and the Frankfurt listing is a key milestone in this process. Listing on the Frankfurt Stock Exchange is an opportunity for Levitee to increase shareholder value by further raising market awareness and expanding our investor base throughout European and global markets.”
The FSE is the world’s third-largest organized exchange-trading market in terms of turnover, dealing in securities, and is the largest stock exchange in Germany. The FSE facilitates advanced electronic trading, settlement and information systems allowing it to meet the growing requirements of cross-border trading.
Levitee Labs (CSE:LVT) is establishing itself as a leader in the integrative wellness space. Through leveraging an M&A regimen that focuses on the centralization of complementary integrative wellness assets, the company aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies.
The company’s current portfolio of assets includes MONKE Nutraceuticals, a company specialized in developing and distributing premium functional mushroom supplements sold via online portals; ACT Medical Centres, a group of five operating pain and addiction treatment clinics in Alberta; Block MD, the first telemedicine company in Alberta to receive provincial approval for telemedicine prescriptions in the addiction treatment space; three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance abuse disorders, mental health conditions, and chronic pain; and Earth Circle Organics, a direct-to-consumer and wholesaler of supplements and superfood products with 180+ SKUs in its product lineup across three brands.
Contact the author at stephen.gunnion@proactiveinvestors.com